Susan Matesanz, MD
Assistant Professor of Clinical Neurology
Attending Physician, The Children's Hospital of Philadelphia
Medical Director, Clinical In Vivo Gene Therapy, CHOP
Department: Neurology
Contact information
3401 Civic Center Blvd
Philadelphia, PA 19146
Philadelphia, PA 19146
Education:
BA (Psychology and Spanish Literature)
Dartmouth College, 2008.
MD
Johns Hopkins School of Medicine, 2014.
Permanent linkBA (Psychology and Spanish Literature)
Dartmouth College, 2008.
MD
Johns Hopkins School of Medicine, 2014.
Selected Publications
Fainberg NA, Keselman D, Matesanz SE, Senthil K.: Feeding Difficulties and Respiratory Failure in a 14-Month-Old Girl. Pediatr Rev 46: 337-340, Jun 2025.Byrne BJ, Flanigan KM, Matesanz SE, Finkel RS, Waldrop MA, D'Ambrosio ES, Johnson NE, Smith BK, Bönnemann C, Carrig S, Rossano JW, Greenberg B, Lalaguna L, Lara-Pezzi E, Subramony S, Corti M, Mercado-Rodriguez C, Leon-Astudillo C, Ahrens-Nicklas R, Bharucha-Goebel D, Gao G, Gessler DJ, Hwu WL, Chien YH, Lee NC, Boye SL, Boye SE, George LA.: Current clinical applications of AAV-mediated gene therapy. Mol Ther 33: 2479-2516, Jun 2025.
Keselman D, Glanzman A, Thelen MY, Prosser LA, McGuire J, Matesanz SE.: Motor function testing rates and outcomes in Duchenne muscular dystrophy with comorbid autism and attention-deficit/hyperactivity disorder. Neuromuscul Disord Mar 2025.
Hamid OA, Hester DM, Matesanz SE, Wright S, Batley KY, Proud CM, Veerapandiyan A.: Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy: A Call for Discussion. Pediatr Neurol Oct 2024.
Susan E Matesanz, Jonathan B Edelson, Katherine A Iacobelli, Erika Mejia, John F Brandsema, Carol A Wittlieb-Weber, Oluwatimilehin Okunowo, Heather Griffis, Kimberly Y Lin: Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States. Neurol Clin Pract 14(4): e200312, August 2024.
Susan E. Matesanz, Karlla W. Brigatti, Millie Young, Sabrina W. Yum, Kevin A. Strauss: Preemptive dual therapy for children at risk for infantile-onset spinal muscular atrophy. Ann Clin Transl Neurol 11(7): 1868-1878, Jul 2024.
Estilow, T., Anderson, K., Flickinger, J., Yum, S., Brandsema, J., Matesanz, S., Kichula E., De Vivo, D., Montes, J., Salazar, R., Connett, K. Mercuri, E., Coratti, G., Finkel, R., Civitello, M., Wells, J., Day, J., Dunnaway Young, S., Duong, T., Gee, R., Darras, B., Pasternak, A., McDermott, M., Martens, B., Zolkipli Cunningham, Z., Glanzman, A. : Quantitative Evaluation of Upper Extremity Strength and Joint Contractures in Spinal Muscular Atrophy Type II: Implications for Motor Function. Cure SMA Annual Conference June 2024.
Allan Glanzman, Mallory Gardner, Nathalie Musey, Jean Flickinger, Jennifer Jones, Susan Matesanz, Elizabeth Kichula, Sabrina Yum, John Brandsema: Serial Casting for Contracture in SMA: A Comparative Analysis with Cerebral Palsy and Duchenne Muscular Dystrophy CureSMA 2023 Annual conference June 2023.
Susan E. Matesanz, Karlla W. Brigatti, Millie Young, Kevin A. Strauss : Muscle Ultrasound in Children with SMA Treated with Early Mono or Dual Therapy. CureSMA 2023 Annual Conference June 2023.
John F. Brandsema, Susan E. Matesanz: Types of Neuromuscular Disease. Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular Disease. Oscar Henry Mayer, MD (eds.). Elsevier Page: 3-22, 2023.